In a prospective cohort study of 1,837 adults hospitalized with COVID-19, selected blood markers of thromboinflammation (i.e., fibrinogen and D-dimer relative to C-reactive protein) predicted cognitive defects at 6-12 months after infection7. The gene discussed is CRP; the disease is Cognitive impairment.